OUTCOME OF TOCILIZUMAB THERAPY IN CHILDREN WITH SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS

Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2018, Vol 7, Issue 23

Abstract

BACKGROUND Globally, 3 lakh children suffer with idiopathic arthritis amongst which systemic is about 10% to 25%. The morbidity of arthritis is severe, mortality is about 2% - 4% and hence different treatment protocols are used. Aims and Objectives- To find out the clinical and laboratory outcome of Tocilizumab in children with SOJIA. MATERIALS AND METHODS It is a descriptive study. Methods- 24 children of above 3 years to sixteen, who satisfied ILAR criteria for systemic onset, who were already on DMARDs and attended the rheumatic care centre at Rajiv Gandhi Govt. General Hospital were included between March 2014 and March 2017. Other types of JIA and very sick children were excluded. Tocilizumab 8 mg/kg was given every month and the clinical and laboratory assessment, ACR disease activity core set index were done at baseline and at 6 months. RESULTS Amongst 24 children, there were 3 dropouts. Tocilizumab was given in 12 doses in 6, 6 doses in 7, 7 doses in 4 and 3 doses in 4. Male: Female seen as 16: 5 or 3.2: 1. Mean age in the cohort was 9.1 ± 0.729. Mean disease duration was 4.09 ± 0.43. Investigation showed Mean ESR 69.05 ± 3.78 and 38.09 ± 2.52; Mean CRP 25.71 ± 4.06 and 5.43 ± 1.30; Mean WBC 18.92 ± 2.66 and 9.54 ± 0.56; Mean platelet 6.27 ± 3.7 and 4.68 ± 0.189 before and after Tocilizumab therapy. CONCLUSION Tocilizumab therapy for systemic JIA reduces systemic activity to large extent along with articular inflammation, seen as drop in CRP and ESR and platelet with improvement in ACR 30% in this study.

Authors and Affiliations

Balameena S. , Ravichandran R.

Keywords

Related Articles

RISK FACTORS ASSOCIATED WITH HYPERTENSION AMONG ADULTS RESIDING IN AN URBAN AREA OF KERALA- A CROSS-SECTIONAL STUDY

BACKGROUND Kerala is an Indian state, which is advanced with respect to various health indicators like infant mortality rate, maternal mortality rate, immunisation coverage, family planning acceptance etc., also social d...

  TYPE 2 LEPRA REACTION WITH ULCERATION (ERYTHEMA NECROTICANS) A CASE REPORT

  Leprosy is a chronic granulomatous disease caused by mycobacterium leprae with wide spectrum of clinical, histopathological and immunological characteristics. Leprosy reactions mainly encountered are type 1 an...

RETROSPECTIVE ANALYSIS OF LSIS VERSUS PHARMACOLOGICAL MANAGEMENT IN ACUTE ANAL FISSURE- A STUDY IN ZONAL SERVICE HOSPITAL

BACKGROUND Acute anal fissure is a quite common and extremely painful condition of anal canal. The prevalence of anal fissures has changed due to change in food habits in the Indian subcontinent. Medical management is a...

 A VARIANT MUSCLE OF THE FLEXOR COMPARTMENT OF FOREARM: A CASE REPORT

 Variations of the muscles are well known and documented. Here we report a unilateral variation of flexor digitorum profundus in the ventral aspect of the distal forearm of an elderly male cadaver. The variant m...

THE EFFECT OF CHAMOMILE OINTMENT ON THE HEALING OF BREASTFEEDING MOTHERS’ NIPPLE SORE- A RANDOMIZED CONTROLLED CLINICAL TRIAL

BACKGROUND AND AIM Breastfeeding is an important factor in the reduction of death and disease attaching during neonatal period. Mother’s nipple sore (MNS) makes the breast feeding experience unpleasant and even leads to...

Download PDF file
  • EP ID EP439323
  • DOI 10.14260/jemds/2018/620
  • Views 48
  • Downloads 0

How To Cite

Balameena S. , Ravichandran R. (2018). OUTCOME OF TOCILIZUMAB THERAPY IN CHILDREN WITH SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS. Journal of Evolution of Medical and Dental Sciences, 7(23), 2746-2748. https://europub.co.uk/articles/-A-439323